Qualcomm Expands Collaboration with Novartis for Connected COPD Therapy

Qualcomm Life, Inc.Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global connected therapy management collaboration. Novartis will leverage Qualcomm Life's connectivity solutions to power its next-generation connected Breezhaler™, the inhaler for its Chronic Obstructive Pulmonary Disease (COPD) portfolio.

Qualcomm Life is developing the reference design for the small, low-power, disposable module to connect the next generation Breezhaler, which is part of Novartis' leading portfolio of COPD treatments comprised of Onbrez™, Seebri™ and Ultibro™, with Ultibro leading the category in the LABA/ LAMA therapy class. The module is designed to seamlessly connect with Qualcomm Life's 2net™ Platform, and can detect and report inhaler usage, as well as the duration of the patient's inhalation which indicates quality of the inhalation.

"This is an exciting time for health care as we see the proliferation of the Internet of Medical Things," said Rick Valencia, senior vice president and general manager, Qualcomm Life, Inc. "Through our expanded collaboration with Novartis, we are able to deliver a frictionless digital health experience to their COPD patients."

Through this collaboration, Novartis aims to be the first company with a completely integrated, connected delivery device that will provide a simple experience for patients, eliminate the need to assemble the device themselves, and enable them to more easily manage their chronic disease. With near-real time data capture from the patient and the connected device, Novartis aims to improve medication adherence and ultimately health outcomes for COPD patients.

Novartis plans to launch the new connected Breezhaler in 2019 following manufacturing, testing and regulatory approvals.

About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other.

2net is a trademark of Qualcomm Incorporated, registered in the United States and other countries.

Most Popular Now

SAP IoT Startup Accelerator

The SAP IoT Startup Accelerator is a structured co-innovation program for selected B2B startups focusing on the Internet of Things. The Accelerator helps startups grow and scale their businesses alongside...

Read more

Pitch Your Digital Health Solution at th…

The second eHealth Roadshow, promoted by the new EU-funded eHealth Hub project, will take place on the 6th of April in Stuttgart, Germany, in the frame of the Medtec Europe...

Read more

SkinVision Unveils Breakthrough Algorith…

Dutch mobile health startup SkinVision has revealed its new algorithm that can detect most common forms of deadly skin cancer. Previously focused on detecting melanoma skin cancer, the app can...

Read more

Wearable AI System can Detect a Conversa…

It's a fact of nature that a single conversation can be interpreted in very different ways. For people with anxiety or conditions such as Asperger's, this can make social situations...

Read more

eHealth Hub Solution Match Call: Hospita…

Solution Match is one of the services offered by the EU-funded initiative eHealth Hub, intending to promote and boost up commercialization. The eHealth Hub aims to provide long-term support to...

Read more

Doctrina Raises €1,020,000 of New Capita…

Doctrina, a start-up company transforming the traditional transfer of knowledge between pharmaceutical companies and pharmacies, has raised a total of €1,020,000 in series A funding. The investment will enable Doctrina...

Read more

Brain-Computer Interface Allows Complete…

A brain-computer interface that can decipher the thoughts of people who are unable to communicate could revolutionize the lives of those living with complete locked-in syndrome according to a new...

Read more

Deep Learning in Healthcare Summit

28 - 01 March 2017, London, UK. Discover advances in deep learning tools and techniques from the world's leading innovators across industry, academia and the healthcare sector. Learn from the experts...

Read more

Teach a Computer to Recognize AML

Researchers have developed the first computer machine-learning model to accurately predict which patients diagnosed with acute myelogenous leukemia, or AML, will go into remission following treatment for their disease and...

Read more

Philips and Diagnostics Development win …

Royal Philips (NYSE: PHG, AEX: PHIA), a leader in HealthTech, and Diagnostics Development, a P&M Venge company spin-off from Uppsala University (Sweden), have demonstrated a proof-of-concept for the rapid and...

Read more

SpinLab - The HHL Accelerator for Startu…

SpinLab - The HHL Accelerator supports entrepreneurial teams in growing and creating innovative businesses. SpinLab's mission is to foster entrepreneurship and innovation in the center of Germany and beyond by...

Read more

Good Outcomes with 'Telepsychiatry' in M…

For people with opioid use disorder receiving medication treatment with buprenorphine, a telepsychiatry approach - using videoconferencing as an alternative to in-person group sessions - provides similar clinical outcomes, reports...

Read more
(HEALTH IT) SPACE - Take a look at who has just Joined